Medline has filed for an initial public offering, according to an Oct. 28 news release from the company.
The company and its backers are seeking to raise about $5 billion through the offering, which would value Medline at as much as $50 billion, Bloomberg reported Oct. 28.
Medline filed a registration statement on Form S-1 with the Securities and Exchange Commission. The number of shares to be offered and the price range have not yet been determined.
If the IPO is completed, Medline intends to list its stock on the Nasdaq Global Select Market under the ticker symbol “MDLN.”
Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan are acting as lead bookrunning managers for the offering.
